rorism at Statens Serum Institut. The center constitutes the point of contact for both national and international BW alarms, requests and sample analysis. NCBD houses the national preparedness operation unit, performs and develops assays for sample analysis, and is engaged in several biodefense research projects as well as intelligence work. Furthermore, the center is developing a biosecurity program.

NCBD participates actively in the Australia Group (AG) and has lately been especially involved in discussions related to the misuse potential of synthetic biology i.e., the de novo synthesis of genes or even organisms from chemically synthesised oligonucleotides.

Tasks of the NCBD, Denmark:

  • Operations (preparedness) (including analysis of samples)

  • Development and testing of assays

  • Biodefence research (European Union projects and national projects)

  • Development of a Biosecurity programme for Denmark

  • International BW work (i.e., EU, AG, Biological and Toxin Weapons Convention (BWC), UN Security Council Resolution (UNSCR) 1540)


Biosecurity legislation in Denmark is expected to be passed by March 2008 and the centre therefore has many activities within the area of biosecurity research and development (R&D).

Our activities within this area have focused on developing objective risk models for assessing the BW potential of various pathogens. We are currently working on an objective risk assessment model for sensitive equipment, technologies and know-how. Furthermore, we are outlining an implementation plan for biosecurity, including awareness activities and codes of conduct.


OECD Best Practice Guidelines on Biosecurity

Innovations derived from research on pathogenic microorganisms promise astounding benefits in health, agriculture and other domains of economic activity. The tremendous advances in biology, biotechnology, genomics, proteomics, synthetic biology and bioinformatics in recent years are almost certain to lead to improved health and well-being. Some such biological resources employed in (R&D) for diagnostics, vaccines

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement